Floatz logo

Tetanus-Cmv Fusion Peptide Vaccine

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)

City of Hope Medical CentervaccinePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) cohort.

Asset / SponsorPhaseRating
Vesanoid
The Affiliated People's Hospital of Ningbo University
Phase 4A
Cytosin-Arabinosid
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 4A
Idarubicine
Technische Universität Dresden
Phase 4A
Arsenic Trioxide
Quetzal Therapeutics
Phase 4BBB
Mitoxantrone
Technische Universität Dresden
Phase 4BBB

View all 50 →

Same molecule, other indications

Tetanus-Cmv Fusion Peptide Vaccine is also rated in:

acute myeloid leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia with 11q23 abnormalitiesDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →